SEC Filings

Filing date	Form	Description	View
08/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012510.pdf 0001415889-23-012510.rtf 0001415889-23-012510.xls
08/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012514.pdf 0001415889-23-012514.rtf 0001415889-23-012514.xls
08/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012517.pdf 0001415889-23-012517.rtf 0001415889-23-012517.xls
08/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012520.pdf 0001415889-23-012520.rtf 0001415889-23-012520.xls
08/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012522.pdf 0001415889-23-012522.rtf 0001415889-23-012522.xls
08/15/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-012271.pdf 0001415889-23-012271.rtf 0001415889-23-012271.xls
08/14/23	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001193125-23-212475.pdf 0001193125-23-212475.rtf 0001193125-23-212475.xls
08/11/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-003012.pdf 0001950047-23-003012.rtf 0001950047-23-003012.xls
08/09/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-014070.pdf 0001558370-23-014070.rtf 0001558370-23-014070.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/07/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-088346.pdf 0001104659-23-088346.rtf 0001104659-23-088346.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.